Potential urine biomarkers from a high throughput metabolomics study of severe sepsis in a large Asian cohort

RSC Advances

Volumn 5, Issue 124, 2015, Pages 102204-102209

  Liang, Qun ^a   Liu, Han ^b   Zhang, Tianyu ^a   Jiang, Yan ^a   Xing, Haitao ^a   Zhang, Ai Hua ^a  

^a Heilongjiang University of Chinese Medicine   (China)

^b SIMON FRASER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; BODY FLUIDS; DIAGNOSIS; DISCRIMINANT ANALYSIS; DRUG PRODUCTS; LEAST SQUARES APPROXIMATIONS; MASS SPECTROMETRY; METABOLITES; SPECTROMETRY; SPHINGOSINES; THROUGHPUT;

CONTROL SUBJECT; EARLY DIAGNOSIS; HIGH THROUGHPUT; HIGH THROUGHPUT SCREENING; NON-TARGETED; ORTHOGONAL SIGNAL CORRECTION; PARTIAL LEAST SQUARES - DISCRIMINANT ANALYSIS; RECEIVER OPERATING CHARACTERISTIC CURVES;

BIOMARKERS;

EID: 84948844927     PISSN: None     EISSN: 20462069     Source Type: Journal    
DOI: 10.1039/c5ra19875e     Document Type: Article

References (25)

1. K. A. Stringer J. G. Younger C. McHugh L. Yeomans M. A. Finkel M. A. Puskarich A. E. Jones J. Trexel A. Karnovsky Whole Blood Reveals More Metabolic Detail of the Human Metabolome than Serum as Measured by 1H-NMR Spectroscopy: Implications for Sepsis Metabolomics Shock 2015 44 3 200 208
2. B. Mickiewicz P. Tam C. N. Jenne C. Leger J. Wong B. W. Winston C. Doig P. Kubes H. J. Vogel Alberta Sepsis Network. Integration of metabolic and inflammatory mediator profiles as a potential prognostic approach for septic shock in the intensive care unit Crit. Care 2015 19 11
3. L. Su H. Li A. Xie D. Liu W. Rao L. Lan X. Li F. Li K. Xiao H. Wang P. Yan X. Li L. Xie Dynamic changes in amino acid concentration profiles in patients with sepsis PLoS One 2015 10 4 e0121933
4. K. R. Walley Biomarkers in sepsis Curr. Infect. Dis. Rep. 2013 15 5 413 420
5. V. Fanos P. Caboni G. Corsello M. Stronati D. Gazzolo A. Noto M. Lussu A. Dessì M. Giuffrè S. Lacerenza F. Serraino F. Garofoli L. D. Serpero B. Liori R. Carboni L. Atzori Urinary (1)H-NMR and GC-MS metabolomics predicts early and late onset neonatal sepsis Early Hum. Dev. 2014 90 S78 S83
6. A. Dessì G. Corsello M. Stronati D. Gazzolo P. Caboni R. Carboni V. Fanos New diagnostic possibilities in systemic neonatal infections: metabolomics Early Hum. Dev. 2014 90 S19 S21
7. Q. Liang C. Wang B. Li Metabolomics of alcoholic liver disease: a clinical discovery study RSC Adv. 2015 5 80381 80387
8. I. Rowe M. Chiaravalli V. Mannella V. Ulisse G. Quilici M. Pema X. W. Song H. Xu S. Mari F. Qian Y. Pei G. Musco A. Boletta Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy Nat. Med. 2013 19 4 488 493
9. T. J. Wang M. G. Larson R. S. Vasan S. Cheng E. P. Rhee E. McCabe G. D. Lewis C. S. Fox P. F. Jacques C. Fernandez C. J. O'Donnell S. A. Carr V. K. Mootha J. C. Florez A. Souza O. Melander C. B. Clish R. E. Gerszten Metabolite profiles and the risk of developing diabetes Nat. Med. 2011 17 4 448 453
10. Y. Zhang Y. Dai J. Wen W. Zhang A. Grenz H. Sun L. Tao G. Lu D. C. Alexander M. V. Milburn L. Carter-Dawson D. E. Lewis W. Zhang H. K. Eltzschig R. E. Kellems M. R. Blackburn H. S. Juneja Y. Xia Detrimental effects of adenosine signaling in sickle cell disease Nat. Med. 2011 17 1 79 86
11. L. Guo M. V. Milburn J. A. Ryals S. C. Lonergan M. W. Mitchell J. E. Wulff D. C. Alexander A. M. Evans B. Bridgewater L. Miller M. L. Gonzalez-Garay C. T. Caskey Plasma metabolomic profiles enhance precision medicine for volunteers of normal health Proc. Natl. Acad. Sci. U. S. A. 2015 pii 201508425
12. T. J. Wang M. G. Larson R. S. Vasan S. Cheng E. P. Rhee E. McCabe G. D. Lewis C. S. Fox P. F. Jacques C. Fernandez C. J. O'Donnell S. A. Carr V. K. Mootha J. C. Florez A. Souza O. Melander C. B. Clish R. E. Gerszten Metabolite profiles and the risk of developing diabetes Nat. Med. 2011 17 4 448 453
13. R. M. Onjiko S. A. Moody P. Nemes Single-cell mass spectrometry reveals small molecules that affect cell fates in the 16-cell embryo Proc. Natl. Acad. Sci. U. S. A. 2015 112 21 6545 6550
14. X. Liu H. Ren D. Peng Sepsis biomarkers: an omics perspective Front. Med. 2014 8 1 58 67
15. R. J. Langley J. L. Tipper S. Bruse R. M. Baron E. L. Tsalik J. Huntley A. J. Rogers R. J. Jaramillo D. O'Donnell W. M. Mega M. Keaton E. Kensicki L. Gazourian L. E. Fredenburgh A. F. Massaro R. M. Otero V. G. Fowler Jr E. P. Rivers C. W. Woods S. F. Kingsmore M. L. Sopori M. A. Perrella A. M. Choi K. S. Harrod Integrative "omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes Am. J. Respir. Crit. Care Med. 2014 190 4 445 455
16. A. Janzer N. J. German K. N. Gonzalez-Herrera J. M. Asara M. C. Haigis K. Struhl Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells Proc. Natl. Acad. Sci. U. S. A. 2014 111 29 10574 10579
17. A. H. Zhang et al., Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets Anal. Chem. 2013 85 7606 7612
18. A. H. Zhang H. Sun X. J. Wang Recent advances in metabolomics in neurological disease, and future perspectives Anal. Bioanal. Chem. 2013 405 8143 8150
19. R. J. Langley E. L. Tsalik J. C. van Velkinburgh S. W. Glickman B. J. Rice C. Wang B. Chen L. Carin A. Suarez R. P. Mohney D. H. Freeman M. Wang J. You J. Wulff J. W. Thompson M. A. Moseley S. Reisinger B. T. Edmonds B. Grinnell D. R. Nelson D. L. Dinwiddie N. A. Miller C. J. Saunders S. S. Soden A. J. Rogers L. Gazourian L. E. Fredenburgh A. F. Massaro R. M. Baron A. M. Choi G. R. Corey G. S. Ginsburg C. B. Cairns R. M. Otero V. G. Fowler Jr E. P. Rivers C. W. Woods S. F. Kingsmore An integrated clinico-metabolomic model improves prediction of death in sepsis Sci. Transl. Med. 2013 5 195ra95
20. B. J. Blaise A. Gouel-Chéron B. Floccard G. Monneret B. Allaouchiche Metabolic phenotyping of traumatized patients reveals a susceptibility to sepsis Anal. Chem. 2013 85 10850 10855
21. B. Mickiewicz G. E. Duggan B. W. Winston C. Doig P. Kubes H. J. Vogel Alberta Sepsis Network. Metabolic profiling of serum samples by 1H nuclear magnetic resonance spectroscopy as a potential diagnostic approach for septic shock Crit. Care Med. 2014 42 5 1140 1149
22. B. Mickiewicz G. C. Thompson J. Blackwood C. N. Jenne B. W. Winston H. J. Vogel A. R. Joffe Alberta Sepsis Network. Development of metabolic and inflammatory mediator biomarker phenotyping for early diagnosis and triage of pediatric sepsis Crit. Care 2015 19 320
23. K. Kamisoglu B. Haimovich S. E. Calvano S. M. Coyle S. A. Corbett R. J. Langley S. F. Kingsmore I. P. Androulakis Human metabolic response to systemic inflammation: assessment of the concordance between experimental endotoxemia and clinical cases of sepsis/SIRS Crit. Care 2015 19 71
24. S. M. Steelman P. Johnson A. Jackson J. Schulze B. P. Chowdhary Serum metabolomics identifies citrulline as a predictor of adverse outcomes in an equine model of gut-derived sepsis Physiol. Genomics 2014 46 10 339 347
25. D. E. Leaf A. Raed M. W. Donnino A. A. Ginde S. S. Waikar Randomized controlled trial of calcitriol in severe sepsis Am. J. Respir. Crit. Care Med. 2014 190 5 533 541